Carol Haddad BS, MS

Carol Haddad is the Oncology Portfolio Lead within Global Clinical Supply Planning. Ms Haddad leads a team of project managers responsible for coordinating and planning all aspects of demand and supply planning for Phase I-IV, collaborative, and investigator initiated/sponsored trials. Specifically, her focus is on global immuno-oncology therapeutic trials with increasing complexity of cold chain, innovator sourced products and rapid study start timelines. Prior to joining Merck, Ms Haddad worked in clinical supply management at Bristol- Meyers Squibb focusing on oncology and infectious disease trials.

Ms Haddad first joined the pharmaceutical industry as a formulation development scientist at DuPont Pharma. Ms Haddad has been in the pharmaceutical industry for 25 years, focusing on clinical supply management for the past 20 years. She is a graduate of Philadelphia College of Pharmacy & Science and holds a Bachelor of Science degree in Pharmacy.